Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 2,123.08% vs -95.11% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 113.04% vs 25.15% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is 115.29% vs -7.59% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 27.78% vs -53.85% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
Compare Quarterly Results Of Lexicon Pharmaceuticals, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 2,123.08% vs -95.11% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 1,706.25% vs 433.33% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 113.04% vs 25.15% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 106.18% vs -18.93% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 115.29% vs -7.59% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 107.07% vs -25.17% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 27.78% vs -53.85% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 4.55% vs 10.00% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






